The Department of Veterans Affairs (VA), through the Network Contracting Office - NCO 15, is initiating a Request for Quotes (RFQ) for the acquisition of an AQUABEAM Robotic System to be used at the Kansas City VA Medical Center. The solicitation number for this process is 36C25525Q0452, with a response deadline set for July 8, 2025, at 11:00 AM Central Time. This procurement is designated as a Total Service-Disabled Veteran Owned Small Business (SDVOSB) Set-Aside and follows a Firm-Fixed Price structure with FOB Destination terms. Further RFQ specifics will be available in Section B upon its expected release on or around July 1, 2025. Interested contractors should submit their quotes and inquiries via email, referencing the solicitation number. Compliance with electronic annual representations and certifications, as well as registration in the System for Award Management (SAM), is required for consideration. The point of contact for this RFQ is Betty Flores at the VA. This presolicitation notice effectively communicates the VA’s procurement intentions and requirements, emphasizing the goal of engaging veteran-owned businesses in fulfilling this need.

This document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs (VA) for the acquisition of an AquaBeam Robotic System to be used at the Kansas City VA Medical Center for treating Benign Prostatic Hyperplasia (BPH). The RFP specifies that this procurement is set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) only. The AquaBeam system provides a minimally invasive treatment option, reducing risks associated with traditional surgeries. Key components required include the AquaBeam Robotic System (Model AB2000), Apogee 2300 Ultrasound System, specific handpieces and scopes, and necessary sterilization equipment. Installation and training for staff must occur within a month post-delivery. The document stipulates a delivery deadline of 60 days after the order is placed and includes various federal clauses that govern contract performance and compliance. This acquisition aims to enhance surgical capabilities within the VA, reducing the need for external referrals and improving patient care for veterans suffering from prostate-related conditions.

The Kansas City VA Medical Center is issuing an amendment to procure the AquaBeam Robotic System for surgical treatment of benign prostatic hyperplasia (BPH). This system offers a minimally invasive approach, utilizing heat-free waterjet therapy, thus aiming to reduce complications associated with traditional invasive surgeries. The amendment modifies the number of deliverables, increasing the AquaBeam Scopes required from four to five. The procurement includes essential components such as an ultrasound system and various accessories needed for the AquaBeam operation. The system’s integration promises enhanced surgical efficacy and reduced recovery times, facilitating treatment for more patients directly within the VA facility, reducing referrals to external community procedures, and ultimately improving care for veterans. The installation and user training are to be completed within a month post-delivery. The document outlines detailed specifications, delivery requirements, and a structured cost schedule for associated items. This procurement aligns with the government's initiative to enhance healthcare delivery and improve service efficiency at veterans' medical facilities.

The document is an amendment to a Request for Proposal (RFP) from the Kansas City VA Medical Center (KCVA) for the procurement of an AquaBeam Robotic System. This system aims to facilitate minimally invasive surgical treatment for patients with benign prostatic hyperplasia (BPH), addressing limitations in current surgical options. The amendment details changes in the quantities of specific deliverables and extends the deadline for offers to July 9, 2025. The AquaBeam system eliminates complications associated with traditional surgeries by using heat-free waterjet therapy that allows for precise tissue removal while minimizing blood loss and recovery time. The required equipment includes the AquaBeam system, ultrasound equipment, scopes, and sterilization tools, with installation and user training mandated within a month post-delivery. The procurement highlights the VA's intent to enhance patient care and reduce reliance on community services, benefiting veterans through improved healthcare access in a timely manner.

The document outlines a sole-source justification for the acquisition of an AquaBeam Robotic System by the Department of Veterans Affairs (VA) for the Kansas City VA Medical Center. The acquisition falls under FAR 13.5 Simplified Acquisition Procedures, which allows for restricted competition when only one responsible source exists to meet agency needs. The AquaBeam Robotic System is specified as a brand-name item necessary for performing Aquablation therapy, a minimally invasive procedure for benign prostate hyperplasia (BPH). The justification includes a detailed description of the system's advanced imaging and surgical capabilities, highlighting its benefits over traditional procedures and its superior patient outcomes. The absence of similar minimally invasive options at the facility has resulted in increased reliance on costly community care. The document emphasizes that obtaining the AquaBeam will enhance service delivery to veterans while reducing associated healthcare costs. The contracting office, located in Leavenworth, KS, plans to ensure a fair price through market research and cost comparisons. This sole-source request aims to resolve operational challenges and improve patient care effectiveness by utilizing specialized technology uniquely suited to meet the VA's surgical requirements.